Integrative Genome-Based Survey of the SARS-CoV-2 Omicron XBB.1.16 Variant

• Published in: International journal of molecular sciences Vol. 24; no. 17; p. 13573
• Main Authors: Scarpa, Fabio, Azzena, Ilenia, Ciccozzi, Alessandra, Giovanetti, Marta, Locci, Chiara, Casu, Marco, Fiori, Pier Luigi, Borsetti, Alessandra, Cella, Eleonora, Quaranta, Miriana, Pascarella, Stefano, Sanna, Daria, Ciccozzi, Massimo
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01-09-2023; MDPI
• Subjects: Comparative analysis; epidemiology; Flexibility; Genetic research; genetics; genome-based survey; Genomes; Genomics; Health aspects; Immune system; molecular evolution; Mutation; Pandemics; phylodynamics; Severe acute respiratory syndrome coronavirus 2; XBB.1.16; Africa
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms241713573

The XBB.1.16 SARS-CoV-2 variant, also known as Arcturus, is a recent descendant lineage of the recombinant XBB (nicknamed Gryphon). Compared to its direct progenitor, XBB.1, XBB.1.16 carries additional spike mutations in key antigenic sites, potentially conferring an ability to evade the immune response compared to other circulating lineages. In this context, we conducted a comprehensive genome-based survey to gain a detailed understanding of the evolution and potential dangers of the XBB.1.16 variant, which became dominant in late June. Genetic data indicates that the XBB.1.16 variant exhibits an evolutionary background with limited diversification, unlike dangerous lineages known for rapid changes. The evolutionary rate of XBB.1.16, which amounts to 3.95 × 10−4 subs/site/year, is slightly slower than that of its direct progenitors, XBB and XBB.1.5, which have been circulating for several months. A Bayesian Skyline Plot reconstruction suggests that the peak of genetic variability was reached in early May 2023, and currently, it is in a plateau phase with a viral population size similar to the levels observed in early March. Structural analyses indicate that, overall, the XBB.1.16 variant does not possess structural characteristics markedly different from those of the parent lineages, and the theoretical affinity for ACE2 does not seem to change among the compared variants. In conclusion, the genetic and structural analyses of SARS-CoV-2 XBB.1.16 do not provide evidence of its exceptional danger or high expansion capability. Detected differences with previous lineages are probably due to genetic drift, which allows the virus constant adaptability to the host, but they are not necessarily connected to a greater danger. Nevertheless, continuous genome-based monitoring is essential for a better understanding of its descendants and other lineages.